Patents by Inventor Niranjan Rao

Niranjan Rao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11508247
    Abstract: An aircraft collision avoidance system includes a plurality of three-dimensional (3D) light detection and ranging (LIDAR) sensors, a plurality of sensor processors, a plurality of transmitters, and a display device. Each 3D LIDAR sensor is enclosed in an aircraft exterior lighting fixture that is configured for mounting on an aircraft, and is configured to sense objects within its field-of-view and supply sensor data. Each sensor processor receives sensor data and processes the received sensor data to determine locations and physical dimensions of the sensed objects. Each transmitter receives the object data, and is configured to transmit the received object data. The display device receives and fuses the object data transmitted from each transmitter, fuses the object data and selectively generates one or more potential obstacle alerts based on the fused object data.
    Type: Grant
    Filed: July 27, 2017
    Date of Patent: November 22, 2022
    Assignee: HONEYWELL INTERNATIONAL INC.
    Inventors: Sunit Kumar Saxena, Niranjan Kalyandurg, Shrikant Rao
  • Publication number: 20220000853
    Abstract: Embodiments of the disclosure relate generally to formulations, methods, kits, and dosage forms for improved topical pharmaceutical formulation comprising an active ingredient, wherein the active ingredient comprises a compound selected from the group consisting of the Formula (I), Formula (II), and Formula (III): The formulations can further comprise a hydrophilic non-ionic surfactant comprising a poloxamer. These formulations are useful in treating inflammation, pruritus and/or pain, or for treating conditions for which the signs and symptoms include inflammation, pruritis and/or pain, by topical administration to a subject.
    Type: Application
    Filed: November 27, 2019
    Publication date: January 6, 2022
    Inventors: Jay Audett, Tarun Goswani, Sameer Suchdeva, Scott K. Thompson, Padam Bansal, Niranjan Rao, Pablo Jimenez
  • Publication number: 20200268685
    Abstract: The present invention provides pharmaceutical compositions given once daily containing at least one therapeutically active ingredient selected from the group consisting of memantine and a pharmaceutically acceptable salt of memantine, and a pharmaceutically acceptable polymeric matrix carrier. The dosage forms of the invention sustain the release of the therapeutically active agent from about 4 to about 24 hours when said dosage form is exposed to aqueous solutions. following entry of said form into a use environment, wherein said dosage form has a dissolution rate of more than about 80% after passage of about 6 hours to about 12 hours following said entry into said use environment.
    Type: Application
    Filed: April 17, 2020
    Publication date: August 27, 2020
    Inventors: Suneel K. Rastogi, Niranjan Rao, Antonia Periclou, Wattanaporn Abramowitz, Mahendra G. Dedhiya, Shashank Mahashabde
  • Patent number: 10695296
    Abstract: Embodiments of the disclosure relate generally to formulations, methods, kits, and dosage forms for improved stability of an active pharmaceutical ingredient, wherein the active ingredient comprises a compound of the formula: wherein X is N, Y is H or optionally substituted C1-C6 alkyl; R4 is morpholine optionally substituted with by C1-C6 alkyl; R7 is C1-C6 alkyl optionally substituted by one or more F; R8? is halogen; and R6 is wherein R10 is H, C1-C6 alkyl, halogen, CN or CF3; R12 is H or halogen; R13 is H, halogen or C1-C6 alkyl; and R17 is H, C1-C6 alkyl, (C1-C6 alkyl)-NH2; and, pharmaceutically acceptable salts and free bases thereof, wherein the active ingredient remains in substantially amorphous form after storage of the pharmaceutical formulation for a predetermined time and conditions.
    Type: Grant
    Filed: July 16, 2018
    Date of Patent: June 30, 2020
    Assignee: Asana BioSciences, LLC
    Inventors: Navnit Shah, Harpreet Sandhu, Ashish Chatterji, Helen Usansky, Louis Denis, Niranjan Rao, Sarper Toker
  • Patent number: 10660868
    Abstract: The present invention provides pharmaceutical compositions given once daily containing at least one therapeutically active ingredient selected from the group consisting of memantine and a pharmaceutically acceptable salt of memantine, and a pharmaceutically acceptable polymeric matrix carrier. The dosage forms of the invention sustain the release of the therapeutically active agent from about 4 to about 24 hours when said dosage form is exposed to aqueous solutions. following entry of said form into a use environment, wherein said dosage form has a dissolution rate of more than about 80% after passage of about 6 hours to about 12 hours following said entry into said use environment.
    Type: Grant
    Filed: July 20, 2016
    Date of Patent: May 26, 2020
    Assignee: Forest Laboratories Holdings Limited
    Inventors: Suneel K Rastogi, Niranjan Rao, Antonia Periclou, Wattanaporn Abramowitz, Mahendra G Dedhiya, Shashank Mahashabde
  • Patent number: 10501274
    Abstract: Monitoring continuous repetitive web sheet defects to determine the causes of such defects by creating unique diagnostic patterns associated with selected components of a web-making machine and employing pattern recognition techniques to analyze and classify web-sheet dynamic and deterministic defect patterns, and identify their root causes. Corrective actions can be effected thereby enhancing machine run-time to minimize late deliveries and improves overall product quality. The technique which is integrated with quality control system can be applied to the manufacturer of paper, packaging, rubber sheets, plastic film, metal foil, and the like.
    Type: Grant
    Filed: July 6, 2017
    Date of Patent: December 10, 2019
    Assignee: Honeywell International Inc.
    Inventors: Balamurugan Ramakrishnan, Gajanan Rothe, Niranjan Rao, Lingathurai Palanisamy, Ajaykumar R Bangur
  • Publication number: 20190105720
    Abstract: A method for trim loss optimization for metal industries includes receiving a selection of one or more orders for metal trimming. The method also includes inputting the one or more orders and multiple machine parameters to a dimension conversion engine, the dimension conversion engine configured to determine a roll width and a roll length for optimally fulfilling each order using decomposition of a three dimensional problem into a two dimensional problem based on spatial decomposition. The method also includes identifying at least one metal forming or conversion machine for processing the one or more orders. The method also includes inputting one or more metal tolerances as edge trim parameters to a trim algorithm. The method also includes determining, using the trim algorithm, a number of parent rolls for fulfilling the one or more orders using the at least one metal forming or conversion machine.
    Type: Application
    Filed: July 20, 2018
    Publication date: April 11, 2019
    Inventors: Gajanan Rothe, Lingathurai Palanisamy, Niranjan Rao, Balamurugan Ramakrishnan
  • Patent number: 10255572
    Abstract: Integration of clothing performance into production planning, scheduling and execution of papermaking machines yields paper products with consistent acceptable quality with minimum downtime and inventory. Linking the selection and operation of papermaking machines to their respective clothing performances improves clothing life cycle. Selected operating parameters of a papermaking machine and historical clothing data are indicative of the machine's clothing condition. Order scheduling engine identifies manufacturing times for particular grades of product and generates order blocks. Papermaking machines are assigned to execute specific order blocks with provision that each machine completes execution of the assigned orders without any anticipated breakage of the wire or felts.
    Type: Grant
    Filed: July 9, 2015
    Date of Patent: April 9, 2019
    Assignee: Honeywell ASCa Inc.
    Inventors: Chandra Azad, Balamurugan Ramakrishnan, Lingathurai Palanisamy, Niranjan Rao, Gajanan Rothe
  • Publication number: 20190015337
    Abstract: Embodiments of the disclosure relate generally to formulations, methods, kits, and dosage forms for improved stability of an active pharmaceutical ingredient, wherein the active ingredient comprises a compound of the formula: wherein X is N, Y is H or optionally substituted C1-C6 alkyl; R4 is morpholine optionally substituted with by C1-C6 alkyl; R7 is C1-C6 alkyl optionally substituted by one or more F; R8? is halogen; and R6 is wherein R10 is H, C1-C6 alkyl, halogen, CN or CF3; R12 is H or halogen; R13 is H, halogen or C1-C6 alkyl; and R17 is H, C1-C6 alkyl, (C1-C6 alkyl)-NH2; and, pharmaceutically acceptable salts and free bases thereof, wherein the active ingredient remains in substantially amorphous form after storage of the pharmaceutical formulation for a predetermined time and conditions.
    Type: Application
    Filed: July 16, 2018
    Publication date: January 17, 2019
    Inventors: Navnit Shah, Harpreet Sandhu, Ashish Chatterji, Helen Usansky, Louis Denis, Niranjan Rao, Sarper Toker
  • Publication number: 20190008868
    Abstract: Embodiments of the disclosure relate generally to formulations, methods of treatment, kits, and dosage forms for treating inflammatory disorders, including atopic dermatitis, or cancer, the formulations comprising an active pharmaceutical ingredient. The formulation provided comprises granules, wherein the granules comprise: micronized active ingredient; one or more granulation binders; one or more fillers; one or more disintegrants; and one or more antioxidants. In one embodiment, the methods of treatment include orally administering the active ingredient to a subject suffering from atopic dermatitis, where the active ingredient is in an amount of about 20 mg to about 80 mg.
    Type: Application
    Filed: April 30, 2018
    Publication date: January 10, 2019
    Inventors: Aruna Railkar, Paras Jariwala, Wantanee Phuapradit, David Zammit, Louis Denis, Niranjan Rao, Helen Usansky, Sandeep Gupta
  • Publication number: 20190010005
    Abstract: Monitoring continuous repetitive web sheet defects to determine the causes of such defects by creating unique diagnostic patterns associated with selected components of a web-making machine and employing pattern recognition techniques to analyze and classify web-sheet dynamic and deterministic defect patterns, and identify their root causes. Corrective actions can be effected thereby enhancing machine run-time to minimize late deliveries and improves overall product quality. The technique which is integrated with quality control system can be applied to the manufacturer of paper, packaging, rubber sheets, plastic film, metal foil, and the like.
    Type: Application
    Filed: July 6, 2017
    Publication date: January 10, 2019
    Inventors: Balamurugan Ramakrishnan, Gajanan Rothe, Niranjan Rao, Lingathurai Palanisamy, Ajaykumar R. Bangur
  • Patent number: 9663261
    Abstract: Product packaging technique including the conversion of paperboard into boxes and packages in a process that includes layout optimization of printing plates and takes into account vendor specifications, box order types, and printing machine constraints.
    Type: Grant
    Filed: November 12, 2014
    Date of Patent: May 30, 2017
    Assignee: Honeywell Limited
    Inventors: Chandra Azad, Gajanan Rothe, Balamurugan Ramakrishnan, Rajasekhar Allkonda, Niranjan Rao
  • Publication number: 20170011317
    Abstract: Integration of clothing performance into production planning, scheduling and execution of papermaking machines yields paper products with consistent acceptable quality with minimum downtime and inventory. Linking the selection and operation of papermaking machines to their respective clothing performances improves clothing life cycle. Selected operating parameters of a papermaking machine and historical clothing data are indicative of the machine's clothing condition. Order scheduling engine identifies manufacturing times for particular grades of product and generates order blocks. Papermaking machines are assigned to execute specific order blocks with provision that each machine completes execution of the assigned orders without any anticipated breakage of the wire or felts.
    Type: Application
    Filed: July 9, 2015
    Publication date: January 12, 2017
    Applicant: Honeywell ASCa Inc.
    Inventors: Chandra Azad, Balamurugan Ramakrishnan, Lingathurai Palanisamy, Niranjan Rao, Gajanan Rothe
  • Publication number: 20160346227
    Abstract: The present invention provides immediate release and modified release oral dosage forms. Specifically, the invention provides modified and immediate release pharmaceutical dosage forms containing memantine that exhibit an enhanced release profile and provide reliable absorption. The dosage forms may be used to treat mild, moderate or severe Alzheimer's disease or neuropathic pain.
    Type: Application
    Filed: August 11, 2016
    Publication date: December 1, 2016
    Inventors: Mahendria G. Dedhiya, Suneel K. Rastogi, Anil Chhettry, Narasimhan Mani, Niranjan Rao, Antonia Periclou
  • Publication number: 20160324803
    Abstract: The present invention provides pharmaceutical compositions given once daily containing at least one therapeutically active ingredient selected from the group consisting of memantine and a pharmaceutically acceptable salt of memantine, and a pharmaceutically acceptable polymeric matrix carrier. The dosage forms of the invention sustain the release of the therapeutically active agent from about 4 to about 24 hours when said dosage form is exposed to aqueous solutions. following entry of said form into a use environment, wherein said dosage form has a dissolution rate of more than about 80% after passage of about 6 hours to about 12 hours following said entry into said use environment.
    Type: Application
    Filed: July 20, 2016
    Publication date: November 10, 2016
    Inventors: Suneel K. Rastogi, Niranjan Rao, Antonia Periclou, Wattanaporn Abramowitz, Mahendra G. Dedhiya, Shashank Mahashabde
  • Publication number: 20160130025
    Abstract: Product packaging technique including the conversion of paperboard into boxes and packages in a process that includes layout optimization of printing plates and takes into account vendor specifications, box order types, and printing machine constraints.
    Type: Application
    Filed: November 12, 2014
    Publication date: May 12, 2016
    Applicant: Honeywell ASCa Inc
    Inventors: Chandra Azad, Gajanan Rothe, Balamurugan Ramakrishnan, Rajasekhar Allkonda, Niranjan Rao
  • Publication number: 20150258031
    Abstract: The present invention provides pharmaceutical compositions given once daily containing at least one therapeutically active ingredient selected from the group consisting of memantine and a pharmaceutically acceptable salt of memantine, and a pharmaceutically acceptable polymeric matrix carrier. The dosage forms of the invention sustain the release of the therapeutically active agent from about 4 to about 24 hours when said dosage form is exposed to aqueous solutions. following entry of said form into a use environment, wherein said dosage form has a dissolution rate of more than about 80% after passage of about 6 hours to about 12 hours following said entry into said use environment.
    Type: Application
    Filed: May 27, 2015
    Publication date: September 17, 2015
    Inventors: Suneel K. RASTOGI, Niranjan RAO, Antonia PERICLOU, Wattanaporn ABRAMOWITZ, Mahendra G. DEDHIYA, Shashank MAHASHABDE
  • Publication number: 20150258042
    Abstract: The present invention provides immediate release and modified release oral dosage forms. Specifically, the invention provides modified and immediate release pharmaceutical dosage forms containing memantine that exhibit an enhanced release profile and provide reliable absorption. The dosage forms may be used to treat mild, moderate or severe Alzheimer's disease or neuropathic pain.
    Type: Application
    Filed: May 27, 2015
    Publication date: September 17, 2015
    Inventors: Mahendra G. DEDHIYA, Suneel K. RASTOGI, Anil CHHETTRY, Narasimhan MANI, Niranjan RAO, Antonia PERICLOU
  • Publication number: 20150148427
    Abstract: The present invention provides pharmaceutical compositions given once daily containing at least one therapeutically active ingredient selected from the group consisting of memantine and a pharmaceutically acceptable salt of memantine, and a pharmaceutically acceptable polymeric matrix carrier. The dosage forms of the invention sustain the release of the therapeutically active agent from about 4 to about 24 hours when said dosage form is exposed to aqueous solutions. following entry of said form into a use environment, wherein said dosage form has a dissolution rate of more than about 80% after passage of about 6 hours to about 12 hours following said entry into said use environment.
    Type: Application
    Filed: January 28, 2015
    Publication date: May 28, 2015
    Inventors: Suneel K. RASTOGI, Niranjan RAO, Antonia PERICLOU, Wattanaporn ABRAMOWITZ, Mahendra G. DEDHIYA, Shashank MAHASHABDE
  • Publication number: 20140348932
    Abstract: The present invention relates to an immediate release solid oral dosage form containing 1-aminocyclohexanes, preferably memantine or neramexane, and optionally a pharmaceutically acceptable coating, wherein the active ingredient exhibits dose proportionality and is released at a dissolution rate of more than about 80% within about the first 60 minutes following entry of said form into a use environment. The dosage form is direct compressed and has a hardness within the range of between about 3 and about 40 Kp, exhibits an average Tmax within the range of about 2 to about 8 hours with an active ingredient load within the range of about 2.5 to about 150 mg. The formulation allows for dose-proportional compositions for once daily or b.i.d. dosing, while maintaining a steady average range of Tmax.
    Type: Application
    Filed: August 6, 2014
    Publication date: November 27, 2014
    Inventors: Yan YANG, Rajiv JANJIKHEL, Niranjan RAO, Antonia PERICLOU, Wattanaporn ABRAMOWITZ, Mahendra G. DEDHIYA, Erhard SEILLER, Bernhard HAUPTMEIER